Doctor profile · Federal record
Dr. LEAH COHEN, M.D.
Pulmonary Disease Physician (CMS: PULMONARY DISEASE) · Student in an Organized Health Care Education/Training Program · DALLAS, TX
- NPI 1699065292
- Accepts Medicare
- MIPS 74.6 / 100 · 2023
- 15 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5323 HARRY HINES BLVD
DALLAS, TX 753907208
(214) 645-1264
fax (214) 645-1264 - Mailing address
-
PO BOX 845347
DALLAS, TX 752847208
Credentials & registration
- NPI registered
- April 2011 — 15 yrs on file
- Profile last updated
- May 22, 2019
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- Texas #R3814
- Medicaid
- TX #376323701
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1699065292. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
829
Distinct HCPCS
9
Medicare allowed
$48,842
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
94729 |
Test to examine how well the lungs exchange gases | 197 | 186 | $9 | |
94010 |
Test to measure expiratory airflow and volume | 115 | 104 | $8 | |
94726 |
Test to determine lung volumes using sensors | 112 | 111 | $11 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 109 | 45 | $118 | |
94060 |
Test to measure expiratory airflow and volume changes before and after medication administration | 102 | 102 | $10 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 89 | 61 | $124 | |
99291 |
Critical care, first 30-74 minutes | 67 | 28 | $202 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 21 | 18 | $178 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 17 | 17 | $165 |
In context: peer comparison
Among 48 peers in this city , average services per provider: 88. This provider delivers 9.4× the peer median.Open Payments
Industry payments received
All-time total
$132
Transactions
2
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $118.59 | |
| ABBVIE INC. | 1 | $13.80 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
330
Patients
65
Total drug cost
$628,734
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Azithromycin | Generic | 83 | 24 | $2,938 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 42 | 15 | $1,987 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 40 | 0 | $21,826 |
| Advair Hfa (Fluticasone Propion/Salmeterol) | Brand | 36 | 14 | $26,705 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 31 | 12 | $19,923 |
| Creon (Lipase/Protease/Amylase) | Brand | 27 | 0 | $132,464 |
| Fluticasone-Salmeterol (Fluticasone Propion/Salmeterol) | Brand | 17 | 0 | $5,254 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 15 | 0 | $15,966 |
| Montelukast Sodium | Generic | 14 | 0 | $249 |
| Trikafta (Elexacaftor/Tezacaftor/Ivacaft) | Brand | 14 | 0 | $393,629 |